No abstract available
Plain language summary
This Viewpoint advocates for improved strategies to measure naloxone distribution and evaluate how effectively naloxone reaches people most likely to experience or witness an opioid overdose.
MeSH terms
-
Drug Overdose* / drug therapy
-
Drug Overdose* / prevention & control
-
Humans
-
Naloxone / therapeutic use
-
Narcotic Antagonists / therapeutic use
-
Opioid-Related Disorders* / drug therapy
Substances
-
Naloxone
-
Narcotic Antagonists